Trial Profile
Lung Clearance Index as an OUTcome parameter to detect the efficacy f Aztreonam Lysine Inhalation in cystic fibrosis patients with near normal spirometry - an observational proof-of concept study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2021
Price :
$35
*
At a glance
- Drugs Aztreonam (Primary) ; Colistimethate sodium; Tobramycin
- Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
- Focus Proof of concept; Therapeutic Use
- Acronyms LCI-OUT
- 24 Oct 2021 Status changed from recruiting to completed.
- 30 Oct 2014 New trial record